Cannabix Technologies Inc. (OTCMKTS:BLOZF – Get Free Report) was the target of a significant growth in short interest in the month of April. As of April 30th, there was short interest totaling 42,321 shares, a growth of 295.0% from the April 15th total of 10,715 shares. Approximately 0.0% of the company’s stock are short sold. Based on an average daily volume of 244,226 shares, the days-to-cover ratio is currently 0.2 days.
Cannabix Technologies Price Performance
Shares of OTCMKTS BLOZF opened at $0.53 on Wednesday. The stock has a market capitalization of $64.39 million, a P/E ratio of -26.29 and a beta of 1.03. The company has a 50-day moving average price of $0.51 and a 200-day moving average price of $0.44. Cannabix Technologies has a 1 year low of $0.33 and a 1 year high of $0.68.
Cannabix Technologies Company Profile
Cannabix Technologies Inc is a Canada-based developer of biosensor technologies focused on the rapid, non-invasive detection of cannabis impairment. The company’s flagship product is a handheld breathalyzer device designed to identify recent use of tetrahydrocannabinol (THC) within minutes of exhalation, offering law enforcement agencies, public safety organizations and workplace safety departments a potential tool to assess impairment in real time.
The Cannabix breathalyzer employs proprietary sensor arrays and on-board algorithms to distinguish THC molecules in breath samples, delivering results without the need for laboratory analysis.
Recommended Stories
- Five stocks we like better than Cannabix Technologies
- Navitas Breaks Out on India Deal, Validating High-Power AI Pivot
- Navy Catalyst Ignites Odysight’s Growth Engine
- AST SpaceMobile Plummets on Galactic Q1 Miss: Can Vertical Integration Save the SpaceX Rival?
- Axon Surged After Earnings and Is Still Down Over 50% From Highs
Receive News & Ratings for Cannabix Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cannabix Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
